STORM Therapeutics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $38.8M
Latest Deal Amount
  • Investors
  • 9

STORM Therapeutics General Information

Description

Developer of small molecule drugs designed to harness the power of RNA epigenetics. The company's drugs tackle diseases through modulating RNA modifying enzymes that help in the treatment of cancer and other diseases, enabling physicians to have access to a target discovery platform for the identification of new drug targets.

Contact Information

Formerly Known As
Iceni Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Primary Office
  • Babraham Research Campus
  • Moneta Building
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

STORM Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series A) 20-May-2019 $38.8M 000.00 Completed Generating Revenue
2. Early Stage VC 07-May-2015 00000 00.000 Completed Generating Revenue
1. Seed Round 01-May-2015 $748K $748K Completed Generating Revenue
To view STORM Therapeutics’s complete valuation and funding history, request access »

STORM Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
To view STORM Therapeutics’s complete cap table history, request access »

STORM Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of small molecule drugs designed to harness the power of RNA epigenetics. The company's drugs tackle diseases
Drug Discovery
Cambridge, United Kingdom
000.00
00000000000 000.00

000000 0

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000 000000000
New York, NY
0 As of 0000
0000
00.00 0000-00-00
00000000000 0000

0 00000

velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, s
000000000000000
Houston, TX
000
0000000000 000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

STORM Therapeutics Competitors (30)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gotham Therapeutics Venture Capital-Backed New York, NY 0 0000 00000000000 0000
0 00000 000000 Angel-Backed Houston, TX 000 0000000000 000
000000000 00000000 Formerly VC-backed San Francisco, CA 000 00000 000000&0 00000
00000 Formerly VC-backed Paris, France 00 00000 000000000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
You’re viewing 5 of 30 competitors. Get the full list »

STORM Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Keith Blundy Ph.D Chief Executive Officer & Board Member
Oliver Rausch Ph.D Chief Scientific Officer
Eric Miska Ph.D Co-Founder & Board Member
Tony Kouzarides Ph.D Scientific Co-Founder & Board Member
Wesley Blackaby Ph.D Vice President Chemistry
You’re viewing 5 of 6 executive team members. Get the full list »

STORM Therapeutics Board Members (17)

Name Representing Role Since
Bruno Montanari Ph.D STORM Therapeutics Board Member 000 0000
Christine Martin Cambridge Enterprise Board Member & Board Observer 000 0000
Christopher O'Donnell Ph.D STORM Therapeutics Board Member 000 0000
Elaine Jones Ph.D Pfizer Ventures Board Member 000 0000
Eric Miska Ph.D STORM Therapeutics Co-Founder & Board Member 000 0000
You’re viewing 5 of 17 board members. Get the full list »

STORM Therapeutics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cambridge Enterprise Angel Group Minority 000 0000 000000 0
Cancer Research UK Venture Capital Minority 000 0000 000000 0
IP Group Venture Capital Minority 000 0000 000000 0
M Ventures Corporate Venture Capital Minority 000 0000 000000 0
Pfizer Ventures Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »